SPACInsider Logo
Monterey Bio Acquisition Corp. (MTRY) Sells Sponsor Shares and Rebrands
by Marlena Haddad on 2023-03-10 at 10:31am

Monterey Bio Acquisition Corp. (NASDAQ:MTRY) announced in an 8-K this morning that its co-sponsors, NorthStar Bio Ventures and Chardan Monterey Investments, entered into a share transfer agreement and will rebrand the company.

As part of the agreement, NorthStar transferred 478,125 shares of MTRY to Chardan for a purchase price of $0.006 per share, which is equal to the initial purchase price it paid for its founder shares.

The co-sponsors then entered into agreements with three new directors of Monterey Bio to transfer an aggregate of 35,000 founder shares to each director. Each of the newly appointed officers and directors has agreed to vote all of their shares of common stock, including any founder shares, in favor of a business combination, and waived certain conversion rights with respect to their founder shares.

As a result, Monterey Bio will undergo a change in management. Sanjeev Satyal tendered his resignation as CEO and will be replaced by Murat Omur, who brings 15 years of investment banking experience in the healthcare M&A space. Mr. Omur serves as Managing Director of Healthcare Investment Banking and Principal Investments at Chardan Capital Markets. Prior to joining Chardan, Mr. Omur was an Executive Director in Healthcare Investment Banking at Nomura Securities.

Additionally, William McKeever stepped down as CFO and director and is to be replaced by Sean McGann, who also brings over 15 years of investment banking and strategy experience. Mr. McGann is a Managing Director in the Principal Investments Group for Chardan Capital Markets, a position he has held since 2020. Previously, Mr. McGann was at Citigroup where he was the Director of Product Strategy for the Corporate and Investment Bank and served as an Investment Banker covering clients in the Financial Technology and Asset Management sectors.

Chris Coleman, Jory Des Jardins and Roderick Hardamon, were appointed as directors. Mr. Hardamon and Mr. Coleman were appointed to the audit committee of the company, and Mr. Hardamon was also designated as the “audit committee financial expert.” Jonas Grossman was appointed as Executive Chairman.

The SPAC announced the pricing of its $100 million IPO in September 2021 but has not yet found a target to combine with. It intends to partner with a biotech company, specifically within the oncology or immunology sector, that has demonstrated success and is primed to thrive in the rapidly evolving biotech industry.

By implementing these new key additions to the board of directors and management team, Monterey hopes to expand its acquisition strategy to include a broader universe of disruptive technology targets.

Recent Posts
by Kristi Marvin on 2023-04-01 at 10:51am

Terms Tracker for the Week Ending March 31, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Filings continue to remain quiet, but SPACs did manage to price two more IPOs this week with TMT Acquisition Corp (Nasdaq: TMTCU) and Trailblazer Merger...

by Marlena Haddad on 2023-03-31 at 5:15pm

Hudson Acquisition I Corp. (NASDAQ:HUDA) announced that it has signed a non-binding letter of intent (LOI) to combine with a pre-clinical-stage biotechnology company. The SPAC did not provide many details on the unnamed target, but disclosed that the biotech company is focused on developing intranasal preventives for major disease-causing respiratory viruses. As a condition to the target...

by Nicholas Alan Clayton on 2023-03-31 at 1:25pm

Heading into April, SPACs are to see eight sponsors and 11 de-SPAC’d companies freed from lock-ups and ready to trade. Most of these lock-up expirations are loaded into the final week of the month, but those hitting this milestone already next week include some of the more interesting transactions of the crop. In particular, MoonLake...

by Marlena Haddad on 2023-03-31 at 11:39am

Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  Shares of Digital World jump after Trump’s indictment, and pair of Delaware Chancery court decisions deny motions to dismiss SPAC shareholder’s fiduciary breach claims Trump-Tied SPAC’s Shares Jump After Historic New York Charge The...

by Kristi Marvin on 2023-03-30 at 7:37pm

Ares Acquisition Corporation II (NYSE:AACT) filed its S-1 yesterday afternoon for a $400 million IPO, marking the second SPAC to file for an IPO in March and the largest since December 20, 2021, when Gores Holdings X Inc. filed for a $725 million SPAC. Ares II intends to focus its search on an established target...

Privacy Policy|Terms Of Use
Copyright © 2023 SPACInsider, Inc. All Rights Reserved